Glucemix

Array
(
    [ID] => 5713
    [post_author] => 16
    [post_date] => 2012-12-27 14:55:57
    [post_date_gmt] => 2012-12-27 17:55:57
    [post_content] => 
Forma farmacéutica:


Comprimidos
Composición:
Cada comprimido contiene: Vildagliptin 50 mg
Acción Terapéutica:
Hipoglucemiante oral.
Indicaciones:
Como tratamiento dual por vía oral en combinación con:

- Metformina, en pacientes con un control insuficiente de la glucemia a pesar de recibir la dosis máxima tolerada de metformina en monoterapia;

- Una sulfonilurea, en pacientes con un control insuficiente de la glucemia a pesar de recibir la dosis máxima tolerada de una sulfonilurea y para los que la metformina no es adecuada debido a contraindicaciones o intolerancia;

- Una tiazolidindiona, en pacientes con un control insuficiente de la glucemia y para los que es adecuado el uso de una tiazolidindiona.
Presentaciones:
Glucemix: Envases por 28 y 56 comprimidos.


    [post_title] => Glucemix
    [post_excerpt] => Hipoglucemiante oral.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => glucemix
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2021-09-22 14:04:37
    [post_modified_gmt] => 2021-09-22 17:04:37
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum/?post_type=productos&p=5713
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 11118
                    [post_author] => 16
                    [post_date] => 2015-02-06 20:33:32
                    [post_date_gmt] => 2015-02-06 20:33:32
                    [post_content] => 
                    [post_title] => Prospecto Glucemix-1
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => prospecto-glucemix-1
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2015-02-06 20:33:32
                    [post_modified_gmt] => 2015-02-06 20:33:32
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2015/02/Prospecto-Glucemix-1.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 11131
                    [post_author] => 16
                    [post_date] => 2015-02-12 17:20:31
                    [post_date_gmt] => 2015-02-12 17:20:31
                    [post_content] => 
                    [post_title] => logo_lanzamiento_grucemix.jpg
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => logo_lanzamiento_grucemix-jpg
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2015-02-12 17:20:31
                    [post_modified_gmt] => 2015-02-12 17:20:31
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/?attachment_id=11131
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/jpeg
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 11122
                    [post_author] => 16
                    [post_date] => 2015-02-09 14:15:54
                    [post_date_gmt] => 2015-02-09 14:15:54
                    [post_content] => 
                    [post_title] => img_prod_glucemix.jpg
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => img_prod_glucemix-jpg-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2015-02-09 14:15:54
                    [post_modified_gmt] => 2015-02-09 14:15:54
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/?attachment_id=11122
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/jpeg
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Glucemix
        )

    [principio_activo] => Array
        (
            [0] => Vildagliptin
        )

    [post_content_formatted] => 
Forma farmacéutica:

Comprimidos
Composición:
Cada comprimido contiene: Vildagliptin 50 mg
Acción Terapéutica:
Hipoglucemiante oral.
Indicaciones:
Como tratamiento dual por vía oral en combinación con:
– Metformina, en pacientes con un control insuficiente de la glucemia a pesar de recibir la dosis máxima tolerada de metformina en monoterapia;
– Una sulfonilurea, en pacientes con un control insuficiente de la glucemia a pesar de recibir la dosis máxima tolerada de una sulfonilurea y para los que la metformina no es adecuada debido a contraindicaciones o intolerancia;
– Una tiazolidindiona, en pacientes con un control insuficiente de la glucemia y para los que es adecuado el uso de una tiazolidindiona.
Presentaciones:
Glucemix: Envases por 28 y 56 comprimidos.


)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/Prospecto-Glucemix-1.pdf
        )

)

anexo_congre_single